| 國立臺灣大學 |
2015 |
Caveat of measuring perfusion indexes using intravoxel incoherent motion magnetic resonance imaging in the human brain
|
Wu, Wen-Chau; Chen, Ya-Fang; Tseng, Han-Min; Yang, Shun-Chung; My, Pei-Chi; 陳雅芳; 吳文超; 楊舜仲 |
| 臺大學術典藏 |
2019-10-18T01:19:48Z |
Caveat of measuring perfusion indexes using intravoxel incoherent motion magnetic resonance imaging in the human brain
|
My P.-C.;Yang S.-C;Tseng H.-M;YA-FANG CHEN;Wu Wen-Chau; Wu Wen-Chau; YA-FANG CHEN; Tseng H.-M; Yang S.-C; My P.-C. |
| 臺大學術典藏 |
2020-09-23T08:35:47Z |
Caveat of measuring perfusion indexes using intravoxel incoherent motion magnetic resonance imaging in the human brain
|
Wu W.-C.; YA-FANG CHEN; Tseng H.-M.; Yang S.-C.; My P.-C. |
| 臺大學術典藏 |
2021-08-20T08:20:02Z |
Caveats in the interpretation of natriuretic peptide levels
|
CHIA-TER CHAO |
| 國家衛生研究院 |
2013-08 |
Caveolar endocytosis is required for human PSGL-1-mediated enterovirus 71 infection
|
Lin, HY;Yang, YT;Yu, SL;Hsiao, KN;Liu, CC;Sia, C;Chow, YH |
| 國立臺灣大學 |
2001 |
caveolin 在轉移肺腺癌的表現，並探討其在腫瘤轉移機制中之角色(1/2)
|
黃佩欣 |
| 國立成功大學 |
2014-06-20 |
Caveolin-1 Alters the Pattern of Cytoplasmic Ca2+ Oscillations and Ca2+-dependent Gene Expression by Enhancing Leukotriene Receptor Desensitization
|
Yeh, Yi-Chun; Tang, Ming-Jer; Parekh, Anant B. |
| 國立成功大學 |
2018-01 |
Caveolin-1 Controls Hyperresponsiveness to Mechanical Stimuli and Fibrogenesis-Associated RUNX2 Activation in Keloid Fibroblasts
|
Hsu;Chao-Kai;Lin;Hsi-Hui;Harn;Hans, I-Chen;Ogawa;Rei;Wang;Yang-Kao;Ho;Yen-Ting;Chen;Wan-Rung;Lee;Yi-Chao;Lee;Julia, Yu-Yun;Shieh;Shyh-Jou;Cheng;Chao-Min;McGrath;John, A.;Tang;Ming-Jer |
| 臺大學術典藏 |
2020-06-30T08:51:24Z |
Caveolin-1 deletion reduces early brain injury after experimental intracerebral hemorrhage
|
Chang C.-F. ;Chen S.-F. ;Tzong-Shyuan Lee ;Lee H.-F. ;Chen S.-F. ;Shyue S.-K.; Chang C.-F.; Chen S.-F.; TZONG-SHYUAN LEE; Lee H.-F.; Chen S.-F.; Shyue S.-K. |
| 臺大學術典藏 |
2022-02-15T05:33:09Z |
Caveolin-1 deletion reduces early brain injury after experimental intracerebral hemorrhage
|
CHE-FENG CHANG; Chen, Shu-Fen; Lee, Tzong-Shyuan; Lee, Hung-Fu; Chen, Szu-Fu; Shyue, Song-Kun |
| 東海大學 |
2015-02-04 |
Caveolin-1 dependent endocytosis enhanced chemosensitivity of TDM-1 in Her-2 positive breast cancer cells
|
趙偉廷; Wei, Wan-Chen; Chung, Yuan-Chiang; Chang, King-Jen; Chao, Wei-Ting |
| 東海大學 |
2015-07 |
Caveolin-1 dependent endocytosis enhances the chemosensitivity of HER-2 positive breast cancer cells to trastuzumab emtansine (T-DM1)
|
趙偉廷; Chung, Yuan-Chiang; Kuo, Jang-Fang; Wei, Wan-Chen; Chang, King-Jen; Chao, Wei-Ting |
| 臺大學術典藏 |
2022-08-12T06:27:32Z |
Caveolin-1 dependent endocytosis enhances the chemosensitivity of HER-2 positive breast cancer cells to trastuzumab emtansine (T-DM1)
|
Chung Y.-C.; Kuo J.-F.; Wei W.-C.; KING-JEN CHANG; Chao W.-T.; Tan M. |
| 國立成功大學 |
2024-09 |
Caveolin-1 differentially regulates the transforming growth factor-O and epidermal growth factor signaling pathways in MDCK cells
|
Hsiao;Shih-Chuan;Liao;Wei-Hsiang;Chang;Heng-Ai;Lai;Yi-Shyun;Chan;Ta-Wei;Chen;Ying-Chi;Chiu;Wen-Tai |
| 國立成功大學 |
2024 |
Caveolin-1 differentially regulates the transforming growth factor-β and epidermal growth factor signaling pathways in MDCK cells
|
Hsiao;S, -C.;Liao;W, -H.;Chang;H, -A.;Lai;Y, -S.;Chan;T, -W.;Chen;Y, -C.;Chiu;W, -T. |
| 國立成功大學 |
2018-05 |
Caveolin-1 down-regulation is required for Wnt5a-Frizzled 2 signalling in Ha-Ras(V12)-induced cell transformation
|
Lin;Hsiu-Kuan;Lin;Hsi-Hui;Chiou;Yu-Wei;Wu;Ching-Lung;Chiu;Wen-Tai;Tang;Ming-Jer |
| 國立成功大學 |
2018 |
Caveolin-1 down-regulation is required for Wnt5a-Frizzled 2 signalling in Ha-RasV12-induced cell transformation
|
Lin, H.-K.;Lin, H.-H.;Chiou, Y.-W.;Wu, C.-L.;Chiu, W.-T.;Tang, M.-J. |
| 東海大學 |
2003 |
Caveolin-1 expression is associated with plaque formation in hypercholesterolemic rabbits
|
Lin, W.-W., Lin, Y.-C., Chang, T.-Y., Tsai, S.-H., Ho, H.-C., Chen, Y.-T., Yang, V.C. |
| 國立臺灣大學 |
2008 |
Caveolin-1 Expression Is Significantly Associated with Drug Resistance and Poor Prognosis in Advanced Non-Small Cell Lung Cancer Patients Treated with Gemcitabine-Based Chemotherapy
|
何肇基; 郭頌鑫; 黃佩欣; 黃馨儀; 楊志新; 楊泮池; HO, CHAO-CHI; KUO, SUNG-HSIN; HUANG, PEI-HSIN; HUANG, HSIN-YI; YANG, CHIH-HSIN; YANG, PAN-CHYR |
| 臺大學術典藏 |
2018-09-10T06:52:57Z |
Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy
|
Chao-Chi Ho and Sung-Hsin Kuo and Pei-Hsin Huang and Hsin-Yi Huang and Chih-Hsin Yang and Pan-Chyr Yang; Sung-Hsin Kuo; CHAO-CHI HO; PEI-HSIN HUANG |
| 臺大學術典藏 |
2008 |
Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy
|
Yang P.-C.; CHIH-HSIN YANG; Huang H.-Y; Huang P.-H; Kuo S.-H; Ho C.-C; Yang P.-C.;Chih-Hsin Yang;Huang H.-Y;Huang P.-H;Kuo S.-H;Ho C.-C |
| 臺大學術典藏 |
2020-07-21T06:46:34Z |
Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy
|
CHAO-CHI HO; Kuo S.-H.; Huang P.-H.; Huang H.-Y.; Yang C.-H.; Yang P.-C. |
| 臺大學術典藏 |
2020-03-05T08:16:43Z |
Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy
|
Ho C.-C.;Kuo S.-H.;Pei-Hsin Huang;Huang H.-Y.;Yang C.-H.;Yang P.-C.; Ho C.-C.; Kuo S.-H.; PEI-HSIN HUANG; Huang H.-Y.; Yang C.-H.; Yang P.-C. |
| 臺大學術典藏 |
2020-12-02T02:34:39Z |
Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy
|
Ho C.-C.;Kuo S.-H.;Huang P.-H.;Huang H.-Y.;Yang C.-H.;Pan-Chyr Yang; Ho C.-C.; Kuo S.-H.; Huang P.-H.; Huang H.-Y.; Yang C.-H.; PAN-CHYR YANG |
| 臺大學術典藏 |
2021-02-23T08:26:39Z |
Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy
|
Ho C.-C.;Sung-Hsin Kuo;Huang P.-H.;Huang H.-Y.;Yang C.-H.;Yang P.-C.; Ho C.-C.; SUNG-HSIN KUO; Huang P.-H.; Huang H.-Y.; Yang C.-H.; Yang P.-C. |
